Geode Capital Management’s Tiziana Life Sciences TLSA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $124K | Buy |
78,204
+319
| +0.4% | +$504 | ﹤0.01% | 4011 |
|
2025
Q1 | $84.1K | Sell |
77,885
-167,837
| -68% | -$181K | ﹤0.01% | 4077 |
|
2024
Q4 | $171K | Buy |
245,722
+27,041
| +12% | +$18.8K | ﹤0.01% | 3954 |
|
2024
Q3 | $210K | Sell |
218,681
-840
| -0.4% | -$806 | ﹤0.01% | 3885 |
|
2024
Q2 | $202K | Buy |
219,521
+3,696
| +2% | +$3.4K | ﹤0.01% | 3906 |
|
2024
Q1 | $93K | Buy |
215,825
+4,658
| +2% | +$2.01K | ﹤0.01% | 4180 |
|
2023
Q4 | $118K | Buy |
211,167
+4,751
| +2% | +$2.65K | ﹤0.01% | 4132 |
|
2023
Q3 | $139K | Buy |
206,416
+4,453
| +2% | +$3K | ﹤0.01% | 4130 |
|
2023
Q2 | $138K | Buy |
201,963
+1,501
| +0.7% | +$1.02K | ﹤0.01% | 4212 |
|
2023
Q1 | $221K | Buy |
200,462
+3,476
| +2% | +$3.82K | ﹤0.01% | 3998 |
|
2022
Q4 | $119K | Buy |
196,986
+2,370
| +1% | +$1.43K | ﹤0.01% | 4332 |
|
2022
Q3 | $151K | Buy |
194,616
+6,399
| +3% | +$4.97K | ﹤0.01% | 4360 |
|
2022
Q2 | $140K | Buy |
188,217
+2,528
| +1% | +$1.88K | ﹤0.01% | 4440 |
|
2022
Q1 | $194K | Buy |
185,689
+43,797
| +31% | +$45.8K | ﹤0.01% | 4400 |
|
2021
Q4 | $136K | Buy |
141,892
+8,021
| +6% | +$7.69K | ﹤0.01% | 4624 |
|
2021
Q3 | $195K | Buy |
133,871
+49,290
| +58% | +$71.8K | ﹤0.01% | 4459 |
|
2021
Q2 | $198K | Buy |
84,581
+69,729
| +469% | +$163K | ﹤0.01% | 4346 |
|
2021
Q1 | $41K | Buy |
+14,852
| New | +$41K | ﹤0.01% | 4419 |
|